This photo provided by Myriad Genetics shows packaging for their PROLARIS sample kits for assessing prostate cancer risk. This kit made available in 2012 will be joined by another genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it.
This photo provided by Myriad Genetics shows packaging for their PROLARIS sample kits for assessing prostate cancer risk. This kit made available in 2012 will be joined by another genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it. Myriad Genetics/ASSOCIATED PRESS
This photo provided by Myriad Genetics shows packaging for their PROLARIS sample kits for assessing prostate cancer risk. This kit made available in 2012 will be joined by another genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it. Myriad Genetics/ASSOCIATED PRESS

With genetic testing, patients can see the future

March 24, 2014 08:00 PM

UPDATED February 15, 2015 10:44 AM

More Videos

  • Triangle pooches bound for the National Dog Show

    Aired on Thanksgiving Day, the show attracts thousands of dogs and millions of viewers. Here are a few of the lucky Raleigh entrants.